• SENSEX 80,710.25
    -308.47 (--0.38%)
  • BANKNIFTY 55,360.25
    -259.10 (--0.47%)
  • One 97
    1,050.95 481.75(%)
  • HDFC Bank
    1,967.00 1,593.20(%)
  • ICICI Bank
    1,440.95 1,153.30(%)
  • Aditya Infotech
    1,104.20 1,104.20(%)
  • Newgen Software
    968.75 1,795.50(%)
  • Godfrey Phillips
    9,891.25 9,891.25(%)
  • Reliance Industr
    1,388.10 1,115.55(%)
  • Jayaswal Neco
    55.85 55.85(%)
  • Tanla Platforms
    685.95 990.00(%)
  • Tata Inv.Corpn.
    7,625.00 8,075.90(%)
  • Infosys
    1,454.75 1,307.10(%)
  • KIOCL
    410.00 453.05(%)
  • APL Apollo Tubes
    1,633.60 1,935.00(%)
  • IndusInd Bank
    848.80 1,498.70(%)
  • Tata Motors
    659.00 1,142.00(%)
  • Chambal Fert.
    570.00 742.45(%)
  • Medplus Health
    865.95 603.00(%)
  • New India Assura
    205.00 278.00(%)
  • M & M
    3,221.15 3,302.90(%)
  • SBI
    803.65 875.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Amrutanjan Health Care Ltd Pharmaceuticals - Indian - Formulations

  • Amrutanjan
  • BSE Code : 17.0
  • ISIN : INE098F01031
686.90 14 (2.07%)
  • As on 05 Aug 2025 (EOD)

  • Today’s Low

    665.60

  • Today’s High

    699.65

  • Open

    668.05

  • Perv Close

    673.00

  • 52W Low

    544.10

  • 52W High

    862.60

Key Indicators

  • P/E(TTM)

    39.16

  • Mar.Cap (₹Cr.)

    1,985.87

  • Div & Yield %

    0.67

  • Book Value(₹)

    112.97

  • Debt-Equity Ratio

    2.07

  • AGM Date

    05-Aug-2025

  • EPS

    17.58

  • P/E Ratio

    39.16

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,985.87

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    2.89

  • BV (₹)

    113.00

  • Sales( ₹ in Cr.)

    451.82

  • NP (in Cr.)

    50.83

  • NP Var(%)

    13.0

  • Div%

    460.0

  • CPS (₹)

    19.80

  • EPS (₹)

    17.60

  • Traded Value (₹ in Lakhs)

    1,990.06

  • 52 Week High

    862.60

  • 52 Week Low

    544.10

  • Price BSE

    688.0

  • Price NSE

    687.00

  • Market Capital( in Cr.)

    1,990.06

  • P/C Ratio

    34.70

  • P/E Ratio

    39.10

  • Price Vs.BV

    17.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 421.23 379.64 405.84 332.84 261.48 253.23
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 421.23 379.64 405.84 332.84 261.48 253.23
Other Income 16.35 14.54 15.38 11.32 8.32 7.13
Stock Adjustments -2.15 1.73 5.50 -5.01 6.97 3.30
Total Income 435.43 395.91 426.72 339.15 276.77 263.66
EXPENDITURE :            
Raw Materials 209.67 183.71 185.96 135.18 124.05 122.16
Power and Fuel Cost 3.84 3.06 2.66 1.76 2.02 1.87
Employee Cost 47.69 48.81 48.23 41.70 39.36 33.36
Other Manufacturing Expenses 9.86 10.38 8.37 6.66 6.78 5.72
Selling and Administration Expenses 89.23 86.95 84.68 64.72 61.45 59.96
Miscellaneous Expenses 6.87 3.92 1.87 2.97 3.96 2.53
Employee Benefit Expenses 47.69 48.81 48.23 41.70 39.36 33.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 367.17 336.83 331.77 252.99 237.62 225.60
Operating Profit 68.25 59.08 94.95 86.16 39.15 38.04
Interest 0.25 0.22 0.58 0.59 0.34 0.20
Gross Profit 68.00 58.86 94.37 85.57 38.81 37.84
Depreciation 6.06 5.21 3.80 3.67 4.36 3.16
Profit Before Tax 61.94 53.65 90.57 81.90 34.45 34.68
Current Tax 15.94 14.01 23.39 19.73 9.43 10.23
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.03 -0.20 0.00 0.98 -0.06 -0.06
Reported Net Profit 44.97 39.83 67.19 61.19 25.08 24.51
Extraordinary Items 0.11 0.02 0.01 0.07 0.00 0.00
Adjusted Net Profit 44.86 39.81 67.18 61.12 25.08 24.51
Adjustment below Net Profit -35.47 0.00 0.00 0.00 -0.63 -0.51
P & L Balance brought forward 239.89 214.72 161.62 105.13 91.44 74.36
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.18 14.67 14.08 4.71 10.76 6.93
P & L Balance carried down 236.21 239.89 214.72 161.62 105.13 91.44
Dividend 0.00 0.00 5.85 4.68 6.14 3.22
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 460.00 460.00 460.00 420.00 210.00 215.00
Dividend Per Share(Rs) 4.60 4.60 4.60 4.20 2.10 2.15
Earnings Per Share-Unit Curr 15.56 13.63 22.99 20.93 8.58 8.39
Earnings Per Share(Adj)-Unit Curr 15.56 13.63 22.99 20.93 8.58 8.39
Book Value 99.78 99.47 90.70 73.75 54.54 49.86
Book Value(Adj)-Unit Curr 99.78 99.47 90.70 73.75 54.54 49.86

Shareholding Pattern

  • Promoter Group

    46.52%

  • Public Share Holding

    53.44%

  • Custodian

    0.04%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,825,803 20.15 5,825,803 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 5,092,900 17.62 5,092,900 3
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,529,487 8.75 2,529,487 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,448,190 46.52 13,448,190 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 438,935 1.52 437,415 231
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25,460 0.09 24,960 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 695,316 2.41 695,316 31
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,183,984 7.55 2,183,984 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,463,293 5.06 1,463,293 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,806,988 16.63 4,804,968 276
2] Non Institution
Bodies Corporate 0 0.00 0 0
Clearing Members 128 0.00 128 2
Directors of their Relatives 36,552 0.13 36,552 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 503,590 1.74 503,590 1,107
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 262,067 0.91 262,063 739
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 588,900 2.04 588,900 2
Individuals holding nominal share capital up to Rs. 1 lakh 8,744,499 30.25 8,287,059 47,264
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 6,170 0.02 6,170 1
Others 391,692 1.35 391,692 2
Sub Total 10,642,925 36.81 10,185,481 49,147
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 12,527 0.04 12,527 1
Total Shares held by Custodians and against which Depository Receipts have been issued 12,527 0.04 12,527 1
Grand Total ( A + B + C ) 28,910,630 100.00 28,451,166 49,431

Company Background

Amrutanjan Health Care LtdPharmaceuticals - Indian - Formulations

  • Amrutanjan Health Care Ltd
  • BSE Code : 17.0
  • ISIN : INE098F01031

  • Incorporation Year

    1936

  • Registered Office

    New 103 Old 42-45 LuzChurch Rd
    Mylapore, Chennai,
    Tamil Nadu-600004

  • Telephone

    91-44-24994164/24994465/24994366

  • FAX

    91-44-24994585

  • Chairman

    S Sambhuprasad

  • Managing Director

    S Sambhuprasad

  • Company Secretary

    M Srinivasan.

  • Auditor

    B S R & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Amrutanjan Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Amrutanjan Healt 688.35 437.58 421.23 39.16 20.84
Abbott India 33,260.70 6,684.73 6,409.15 49.97 44.95
Astrazeneca Phar 8,853.35 1,756.92 1,716.29 191.22 32.94
P & G Health Ltd 6,185.55 1,166.89 1,151.26 34.16 39.76
Glaxosmi. Pharma 2,840.30 3,866.05 3,723.49 51.08 58.72
Cipla 1,499.25 20,029.57 19,044.85 22.41 21.40
Novartis India 943.65 398.23 356.27 22.67 16.64
Fermenta Biotec. 360.00 442.21 430.53 15.67 17.61
Guj. Themis Bio. 358.25 174.19 169.82 87.59 44.82
Bliss GVS Pharma 179.40 703.42 667.20 26.82 9.16
Ambalal Sarabhai 32.11 19.33 4.04 29.73 2.10